Literature DB >> 8880574

Clinical and genetic heterogeneity of hypochondroplasia.

F Rousseau1, J Bonaventure, L Legeai-Mallet, H Schmidt, J Weissenbach, P Maroteaux, A Munnich, M Le Merrer.   

Abstract

Hypochondroplasia (HCH) is an autosomal dominant condition characterised by short stature, micromelia, and lumbar lordosis. In a series of 29 HCH probands (13 sporadic cases, 16 familial cases), we tested their DNA for the N540K recurrent mutation previously described in the proximal tyrosine kinase domain of the FGFR3 gene on chromosome 4p16.3, and we detected this mutation in 21/29 HCH patients. Interestingly, three familial cases were clearly unlinked to chromosome 4p16.3. Reviewing the clinical and radiological manifestations of the disease a posteriori, we observed that the N540K mutation was associated with relative macrocrania with a high and large forehead and short hands. By contrast, in the three pedigrees inconsistent with linkage to chromosome 4p16.3, the clinical phenotype was milder, macrocephaly and shortening of the long bones was less obvious, the hands were normal, and no metaphyseal flaring was noted. This study supports the view that HCH is a clinically and genetically heterogeneous condition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880574      PMCID: PMC1050728          DOI: 10.1136/jmg.33.9.749

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  Observations suggesting allelism of the achondroplasia and hypochondroplasia genes.

Authors:  V A McKusick; T E Kelly; J P Dorst
Journal:  J Med Genet       Date:  1973-03       Impact factor: 6.318

2.  Possible genetic heterogeneity in hypochondroplasia.

Authors:  I Stoilov; M W Kilpatrick; P Tsipouras; T Costa
Journal:  J Med Genet       Date:  1995-06       Impact factor: 6.318

3.  A common FGFR3 gene mutation in hypochondroplasia.

Authors:  P Prinos; T Costa; A Sommer; M W Kilpatrick; P Tsipouras
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

4.  Achondroplasia and hypochondroplasia. Clinical variation and spinal stenosis.

Authors:  R Wynne-Davies; W K Walsh; J Gormley
Journal:  J Bone Joint Surg Br       Date:  1981

5.  Achondroplasia is defined by recurrent G380R mutations of FGFR3.

Authors:  G A Bellus; T W Hefferon; R I Ortiz de Luna; J T Hecht; W A Horton; M Machado; I Kaitila; I McIntosh; C A Francomano
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

6.  A gene for achondroplasia-hypochondroplasia maps to chromosome 4p.

Authors:  M Le Merrer; F Rousseau; L Legeai-Mallet; J C Landais; A Pelet; J Bonaventure; M Sanak; J Weissenbach; C Stoll; A Munnich
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

7.  The gene for achondroplasia maps to the telomeric region of chromosome 4p.

Authors:  M Velinov; S A Slaugenhaupt; I Stoilov; C I Scott; J F Gusella; P Tsipouras
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

8.  Hypochondroplasia: clinical and radiological aspects in 39 cases.

Authors:  B D Hall; J Spranger
Journal:  Radiology       Date:  1979-10       Impact factor: 11.105

9.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.

Authors:  F Rousseau; J Bonaventure; L Legeai-Mallet; A Pelet; J M Rozet; P Maroteaux; M Le Merrer; A Munnich
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

10.  [Hypochondroplasia. Review of 80 cases].

Authors:  P Maroteaux; P Falzon
Journal:  Arch Fr Pediatr       Date:  1988-02
View more
  14 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

Review 2.  FGFR3-related dwarfism and cell signaling.

Authors:  Daisuke Harada; Yoshitaka Yamanaka; Koso Ueda; Hiroyuki Tanaka; Yoshiki Seino
Journal:  J Bone Miner Metab       Date:  2008-12-09       Impact factor: 2.626

3.  Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.

Authors:  G A Bellus; E B Spector; P W Speiser; C A Weaver; A T Garber; C R Bryke; J Israel; S S Rosengren; M K Webster; D J Donoghue; C A Francomano
Journal:  Am J Hum Genet       Date:  2000-10-27       Impact factor: 11.025

4.  Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.

Authors:  Hwa Young Kim; Jung Min Ko
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-06-30

5.  Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience : prenatal diagnosis in FGFR3 gene.

Authors:  M J Trujillo-Tiebas; M Fenollar-Cortés; I Lorda-Sánchez; J Díaz-Recasens; A Carrillo Redondo; C Ramos-Corrales; C Ayuso
Journal:  J Assist Reprod Genet       Date:  2009-09-30       Impact factor: 3.412

6.  Clinical and Radiologic Evaluation of an Individual with Hypochondroplasia and a Novel FGFR3 Mutation.

Authors:  Rosario Ramos Mejía; Miriam Aza-Carmona; Mariana Del Pino; Karen E Heath; Virginia Fano; Maria Gabriela Obregon
Journal:  J Pediatr Genet       Date:  2019-09-02

Review 7.  Genetic architecture of body size in mammals.

Authors:  Kathryn E Kemper; Peter M Visscher; Michael E Goddard
Journal:  Genome Biol       Date:  2012       Impact factor: 13.583

8.  Hypochondroplasia in a child with 1620C>G (Asn540Lys) mutation in FGFR3.

Authors:  Hüseyin Anıl Korkmaz; Filiz Hazan; Ceyhun Dizdarer; Ajlan Tükün
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-11-12

9.  FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry.

Authors:  Yuan Xue; Angela Sun; P Betty Mekikian; Jorge Martin; David L Rimoin; Ralph S Lachman; William R Wilcox
Journal:  Mol Genet Genomic Med       Date:  2014-08-05       Impact factor: 2.183

10.  Bilateral ossiculoplasty in 1 case of achondroplasia.

Authors:  Jongyoon Jung; Chulwon Yang; Sunkyu Lee; June Choi
Journal:  Korean J Audiol       Date:  2013-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.